Yeah thankfully that won't happen (assuming all goes well with the FDA). TH is only needed when they need time to discuss, investigate, analyse something etc. where they need to involve other parties (where the risk of leaks is high)
That's not the case for the FDA when they approve something, so the only reason for a TH will be if the company needs to do that as a result of the FDA decision (which would not be good)
BOT - Anything but charting, page-5960
-
- There are more pages in this discussion • 3,674 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.0¢ |
Change
0.015(4.76%) |
Mkt cap ! $597.3M | |||
| Open | High | Low | Value | Volume |
| 32.5¢ | 33.5¢ | 32.3¢ | $1.265M | 3.862M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 129446 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.0¢ | 131308 | 2 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |